Goblet Cell Degranulation Produced by Intranasal Tear Neurostimulator (ITN) in Dry Eye Disease

* Capable of giving verbal and signed informed consent, which includes compliance with the requirements and restrictions listed in the ICF and in this protocol * Have not worn contact lenses for at least 7 days prior to the screening visit and are willing to forego the use of contact lenses for the duration of the study * The participant should be literate, able to speak English, and able to complete questionnaires independently

* Chronic or recurrent epistaxis, coagulation disorders or other conditions that, in the opinion of the investigator, may lead to clinically significant increased bleeding * Nasal or sinus surgery (including history of application of nasal cautery) or significant trauma to these areas * Cardiac demand pacemaker, implanted defibrillator or other implanted electronic device * Corneal transplant in either or both eyes * Current enrollment in an investigational drug or device study or participation in such a study within 30 days of entry into this study * Women who are pregnant, planning a pregnancy, or nursing throughout the study